Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 5, 1999, Pages 441-450

  Alvarez Salas, Luis M ^a,b   Arpawong, Thalida E ^a   Dipaolo, Joseph A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; PROTEIN P53; RIBONUCLEASE H; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; MOUSE; OSMOTIC PUMP; PRIORITY JOURNAL; TUMOR CELL LINE; UTERINE CERVIX TUMOR; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS; TUMOR VIRUS;

EID: 0032740776     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.441     Document Type: Article

References (15)

1. AGRAWAL, S., TANG, J.Y., and BROWN, D.M. (1990). Analytical study of phosphorothioate analogues of oligodeoxynucleotides using high-performance liquid chromatography. J. Chromatogr. 509, 396-399.
2. AGRAWAL, S., JIANG, Z., ZHAO, Q., SHAW, D., CAI, Q., ROSKEY, A., CHANNAVAJJALA, L., SAXINGER, C., and ZHANG, R. (1997). Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc. Natl. Acad. Sci. USA 94, 2620-2625.
3. AKHTAR, S., KOLE, R., and JULIANO, R.L. (1991). Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 49, 1793-1801.
4. ALVAREZ-SALAS, L.M., WILCZYNSKI, S.P., BURGER, R.A., MONK, B.J., and DIPAOLO, J.A. (1995). Polymorphism of the HPV-16 E6 gene of cervical carcinoma. Int. J. Oncol. 7, 261-266.
5. ALVAREZ-SALAS, L.M., CULLINAN, A.E., SIWKOWSKI, A., HAMPEL, A., and DIPAOLO, J.A. (1998). Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc. Natl. Acad. Sci. USA 95, 1189-1194.
6. ANAZODO, M.I., WAINBERG, M.A., FRIESEN, A.D., and WRIGHT, J.A. (1995). Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome. J. Virol. 69, 1794-1801.
7. ATKINSON, T., and SMITH, M. (1984). Oligonucleotide Synthesis: A Practical Approach. (IRL Press, Washington, DC).
8. BAKER, C.C., PHELPS, W.C., LINDGREN, V., BRAUN, M.J., GONDA, M.A., and HOWLEY, P.M. (1987). Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61, 962-971.
9. BOIZIAU, C., and TOULME, J.J. (1991). Modified oligonucleotides in rabbit reticulocytes: uptake, stability and antisense properties. Biochimie 73, 1403-1408.
10. CALABRETTA, B. (1991). Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Cancer Res. 51, 4505-4510.
11. COHEN, J.S. (1991). Informational drugs: a new concept in pharmacology. Antisense Res. Dev. 1, 191-193.
12. COTTEN, M., SCHAFFNER, G., and BIRNSTIEL, M.L. (1989). Ribozyme, antisense RNA, and antisense DNA inhibition of U7 small nuclear ribonucleoprotein-mediated histone pre-mRNA processing in vitro. Mol. Cell. Biol. 9, 4479-4487.
13. ZAMECNIK, P.C., and STEPHENSON, M.L. (1978). Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75, 280-284.
14. ZERFASS, K., SCHULZE, A., SPITKOVSKY, D., FRIEDMAN, V., HENGLEIN, B., and JANSEN-DURR, P. (1995). Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69, 6389-6399.
15. ZUR HAUSEN, H., and DE VILLIERS, E.M. (1994). Human papillomaviruses. Annu. Rev. Microbiol. 48, 427-447.